LINC00973/DTX3L軸は,非小細胞肺がんの進行を促進し,治療目標として機能します
Yanke Chen1,2, Yu Qian1, Jiayuan Shi1
1Department of Laboratory Medicine, School of Medicine Jiangsu University Zhenjiang China.
Smart medicine
|February 13, 2026
まとめ
長い非コーディングRNAのLINC00973は,DTX3Lを安定させ,AKTシグナル伝達を活性化することによって,非小細胞肺がん (NSCLC) の進行を促します. LINC00973は,NSCLC治療の潜在的な治療標的である.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- RNA 生物学 RNA 生物学
背景:
- 長い非コーディングRNA (lncRNAs) は,がん生物学における重要な調節因子である.
- 非小細胞肺がん (NSCLC) の多くのlncRNAsの役割は完全に理解されていません.
- 新種のlncRNAとその機能を特定することは,がん治療に不可欠です.
研究 の 目的:
- NSCLCにおけるLINC00973の役割を調査する.
- NSCLCにおける治療標的としてのLINC00973の可能性を調査する.
主な方法:
- NSCLC組織と隣接する非腫瘍サンプルの高通量シーケンシング.
- インビトロ機能検査 (細胞増殖,移動,侵入,アポトーシス).
- マウスモデルにおけるin vivo研究とエクソソーム媒介のsiRNA伝達.
主要な成果:
- LINC00973はNSCLC腫瘍において著しく上調され,予後不良と関連していました.
- LINC00973 ノックダウンはNSCLCの細胞成長と転移を阻害し,過剰発現は逆効果を示した.
- LINC00973はDTX3Lを安定させ,AKT経路を活性化し,エクソソーム媒介のsiRNA配送は腫瘍の成長を抑制しました.
結論:
- LINC00973は,腫瘍の進行を促進することによって,NSCLCにおける腫瘍性lncRNAとして作用します.
- LINC00973は,NSCLC治療の有望な治療標的である.
- LINC00973-ターゲティングsiRNAのエクソソーム媒介による配送は,治療の可能性を示しています.
関連する概念動画
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:29Self-Serving Bias
250
Self-serving bias is a cognitive phenomenon in which individuals attribute positive outcomes to internal factors such as their abilities, intelligence, or effort while attributing negative outcomes to external circumstances. This cognitive distortion helps maintain self-esteem but can also impede objective self-assessment.Theoretical Explanations of Self-Serving BiasTwo primary theories explain the self-serving bias: the cognitive explanation and the motivational explanation.The cognitive...
250
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:40The Eukaryotic Promoter Region
19.0K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
01:37Hypothalamic-Pituitary Axis
66.6K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
66.6K
01:47Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K